|
⚲
|
| Keyboard |
| Struthers Richard Scott
✚
|
|
|---|---|
| CIK # | 0001746298 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001746298] | |
| 4 | [0001746298] | |
| 5 | [0001746298] | |
| SC 13G | [0001746298] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Struthers Richard Scott | Crinetics Pharmaceuticals Inc | [2020-02-11] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Struthers Richard Scott | |
| Crinetics Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-03-16 | Sell | 13,196 | $37.11 | 489,704 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-03-16 | Sell | 8,785 | $37.77 | 331,809 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2026-02-23 | Grant | 228,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2026-02-23 | Grant | 62,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-12-18 | Option exercise | 16,342 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-12-18 | Option exercise | 16,342 | $9.28 | 151,654 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-12-18 | Option exercise | 28,400 | $15.29 | 434,236 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-12-18 | Option exercise | 28,400 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-05-14 | Gift | 90,400 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-05-14 | Gift | 90,400 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-04-02 | Option exercise | 81,270 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-04-02 | Option exercise | 81,270 | $1.91 | 155,226 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-03-19 | Sell | 16,463 | $34.17 | 562,541 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-03-19 | Sell | 875 | $34.83 | 30,476 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2025-02-20 | Grant | 89,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2025-02-20 | Grant | 313,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-12-02 | Sell | 10,000 | $57.57 | 575,700 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-05-08 | Sell | 107,448 | $49.40 | 5,307,931 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-05-08 | Option exercise | 107,448 | $9.28 | 997,117 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (Right to Buy) · derivative
|
2024-05-08 | Option exercise | 107,448 | $0.00 | |
| showing 20 of 76 most recent transactions | |||||